Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

Aspirin reduces the risk for colorectal cancer in high-risk groups, such as Lynch syndrome, but shows no benefit in the ...

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

Sona Nanotech Inc (CSE:SONA, OTCQB:SNANF) revealed promising new study results indicating that its Targeted Hyperthermia ...

Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...

Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

A new public service announcement campaign was launched by the Hawai‘i State Department of Health to encourage adults to get ...

ROCHESTER, Minn. — A new treatment combining immunotherapy with chemotherapy after surgery cut the risk of cancer coming back ...

A 49-year-old mom thought her symptoms were a UTI. It was stage 4 colorectal cancer that had spread to her liver. A new ...